Conformational changes in phosphoglucose isomerase induced by ligand binding

Journal of Molecular Biology

Volumn 323, Issue 1, 2002, Pages 77-84

  Arsenieva, Diana ^a   Jeffery, Constance J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Autocrine motility factor; Conformational change; Induced fit; Phosphoglucose isomerase; Receptor binding

Indexed keywords

AMINO ACID; GLUCOSE 6 PHOSPHATE ISOMERASE;

AMINO ACID SEQUENCE; ARTICLE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; HUMAN; ISOMERISM; LIGAND BINDING; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RABBIT;

ORYCTOLAGUS CUNICULUS;

EID: 0036397874     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(02)00892-6     Document Type: Article

References (42)

1. Morgan, M. J. (1981). The pentose phosphate pathway: evidence for the indispensable role of glucose-phosphate isomerase. FEBS Letters, 130, 124-126.
2. Kugler, W. & Lakomek, M. (2000). Glucose-6-phosphate isomerase deficiency. Balliere's Clin. Haematol. 13, 89-101.
3. Read, J., Pearce, J., Li, X., Muirhead, H., Chirgwin, J. & Davies, C. (2001). The crystal structure of human phosphoglucose isomerase at 1.6 Å resolution: implications for catalytic mechanism, cytokine activity and haemolytic anaemia. J. Mol. Biol. 309, 447-463.
4. Baronciani, L., Zanella, A., Bianchi, P., Zappa, M., Alfinito, F., Iolascon, A. et al. (1996). Study of the molecular defects in glucose phosphate isomerase-deficient patients affected by chronic hemolytic anemia. Blood, 88, 2306-2310.
5. Whitelaw, A. G., Rogers, P. A., Hopkinson, D. A., Gordon, H., Emerson, P. M., Darley, J. H. et al. (1979). Congenital haemolytic anaemia resulting from glucose phosphate isomerase deficiency: genetics, clinical picture, and prenatal diagnosis. J. Med. Genet. 16, 189-196.
6. Schroter, W., Eber, S. W., Bardosi, A., Gahr, M., Gabriel, M. & Sitzmann, F. C. (1985). Generalised glucosephosphate isomerase (GPI) deficiency causing haemolytic anaemia, neuromuscular symptoms and impairment of granulocytic function: a new syndrome due to a new stable GPI variant with diminished specific activity (GPI Homburg). Eur. J. Pediatr. 144, 301-305.
7. Chaput, M., Claes, V., Portetelle, D., Cludts, I., Cravador, A., Burny, A. et al. (1988). The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature, 332, 454-455.
8. Faik, P., Walker, J. I., Redmill, A. A. & Morgan, M. J. (1988). Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3′ sequences. Nature, 332, 455-457.
9. Watanabe, H., Takehana, K., Date, M., Shinozaki, T. & Raz, A. (1996). Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res. 56, 2960-2963.
10. Xu, W., Seiter, K., Feldman, E., Ahmed, T. & Chiao, J. W. (1996). The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood, 87, 4502-4506.
11. Liotta, L. A., Mandler, R., Murano, G., Katz, D. A., Gordon, R. K., Chiang, P. K. & Schiffmann, E. (1986). Tumor cell autocrine motility factor. Proc. Natl Acad. Sci. USA, 83, 3302-3306.
12. Leung, K. & Chiao, W. (1985). Human leukemia cell maturation induced by a T-cell lymphokine isolated from medium conditioned by normal lymphocytes. Proc. Natl Acad. Sci. USA, 82, 1209-1213.
13. Silletti, S. & Raz, A. (1993). Autocrine motility factor is a growth factor. Biochem. Biophys. Res. Commun. 194, 446-457.
14. Nabi, I. R., Watanabe, H., Silletti, S. & Raz, A. (1991). Tumor cell autocrine motility factor receptor. Experientia Suppl. 59, 163-177.
15. Shimizu, K., Tani, M., Watanabe, H., Nagamachi, Y., Niinaka, Y., Shiroishi, T. et al. (1999). The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein. FEBS Letters, 456, 295-300.
16. Cao, M.-J., Osatomi, K., Matsuda, R., Ohkubo, M., Hara, K. & Ishihara, T. (2000). Purification of a novel serine proteinase inhibitor from the skeletal muscle of white croaker (Argyrosomus argentatus). Biochem. Biophys. Res. Commun. 272, 485-489.
17. Matsumoto, I., Staub, A., Benoist, C. & Mathis, D. (1999). Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science, 286, 1732-1734.
18. Schaller, M., Burton, D. R. & Ditzel, H. J. (2001). Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model an human disease. Nature Immunol. 2, 746-753.
19. Matsumoto, I., Maccioni, M., Lee, D. M., Maurice, M., Simmons, B., Brenner, M. et al. (2002). How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nature Immunol. 3, 360-365.
20. Wipke, B. T., Wang, Z., Kim, J., McCarthy, T. J. & Allen, P. M. (2002). Dynamic visualization of a joint-specific autoimmune response through positron emission tomography. Nature Immunol. 3, 366-372.
21. Shaw, P. J. & Muirhead, H. (1997). Crystallographic structure analysis of glucose 6-phosphate isomerase at 3.5 Å resolution. J. Mol. Biol. 109, 475-485.
22. Sun, Y. J., Chou, C. C., Chen, W. S., Wu, R. T., Meng, M. & Hsiao, C. D. (1999). The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin. Proc. Natl Acad. Sci. USA, 96, 5412-5417.
23. Chou, C. C., Sun, Y. J., Meng, M. & Hsiao, C. D. (2000). The crystal structure of phosphoglucose isomerase/autocrine motility factor/neuroleukin complexed with its carbohydrate phosphate inhibitors suggests its substrate/receptor recognition. J. Biol. Chem. 275, 23154-23160.
24. Lee, J. H., Chang, K. Z., Patel, V. & Jeffery, C. J. (2001). Crystal structure of rabbit phosphoglucose isomerase complexed with its substrate D-fructose 6-phosphate. Biochemistry, 40, 7799-7805.
25. Jeffery, C. J., Bahnson, B. J., Chien, W., Ringe, D. & Petsko, G. A. (2000). Crystal structure of rabbit phosphoglucose isomerase, a glycolytic enzyme that moonlights as neuroleukin, autocrine motility factor, and differentiation mediatior. Biochemistry, 39, 955-964.
26. Jeffery, C. J., Hardré, R. & Salmon, L. (2001). Crystal structure of rabbit phosphoglucose isomerase complexed with 5-phospho-D-arabinonate identifies the role of Glu357 in catalysis. Biochemistry, 40, 1560-1566.
27. Arsenieva, D. A., Hardré, R., Salmon, L. & Jeffery, C. (2002). The crystal structure of rabbit phospho-glucose isomerase complexed with 5-phospho-D-arabinonohydroxamic acid. Proc. Natl Acad. Sci. USA, 99, 5872-5877.
28. Dyson, J. & Noltmann, E. A. (1968). The effect of pH and temperature on the kinetic parameters of phosphoglucose isomerase. J. Biol. Chem. 243, 1401-1414.
29. Noltmann, E. A. (1972). Aldose-ketose isomerases. In The Enzymes, vol. 6, pp. 271-301, Academic Press, New York.
30. Hardré, R., Salmon, L. & Opperdoes, F. R. (2000). Competitive inhibition of Trypanosoma brucei phos-phoglucose isomerase by D-arabinose-5-phosphate derivatives. J. Enzyme Inhib. 15, 509-515.
31. Rocchia, W., Sridharan, S., Nicholls, A., Alexov, E., Chiabrera, A. & Honig, B. (2002). Rapid grid-based construction of the molecular surface and the use of induced surface charge to calculate reaction field energies: applications to the molecular systems and geometric objects. J. Comput. Chem. 23, 128-137.
32. Nicholls, A., Sharp, K. A. & Honig, B. (1991). Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins: Struct. Funct. Genet. 11, 281-296.
33. Niinaka, Y., Haga, A., Negishi, A., Yoshimasu, H., Raz, A. & Amagasa, T. (2002). Regulation of cell motility via high and low affinity autocrine motility factor (AMF) receptor in human oral squamous carcinoma cells. Oral. Oncol. 38, 49-55.
34. Chirgwin, J., Parsons, T. F. & Noltmann, E. A. (1975). Mechanistic implications of the pH independence of inhibition of phosphoglucose isomerase by neutral sugar phosphates. J. Biol. Chem. 250, 7277-7279.
35. Hardré, R., Bonnette, C., Salmon, L. & Gaudemer, A. (1998). Synthesis and evaluation of a new inhibitor of phosphoglucose isomerases: the enediolate analogue 5-phospho-D-arabinohydroxamate. Bioorg. Med. Chem. Letters, 8, 3435-3438.
36. Otwinowski, Z. & Minor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. In Macromolecular Crystallography, Part A (Carter, C. W. Jr & Sweet, R. M., eds), pp. 307-326, Academic Press, New York.
37. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W. et al. (1998). Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallog. sect. D, 54, 905-921.
38. Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. (1991). Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A, 47, 110-119.
39. Brunger, A. T. (1992). The free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature, 355, 472-475.
40. Collaborative Computational Project Number 4 (1994). The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D, 50, 760-763.
41. SYBYL 6.5, Tripos Inc., 1699 South Hanley Rd, St. Louis, MI 63144, USA.
42. Esnouf, R. (1997). An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. 15, 133-138.